The American Healthcare Quality Board publishes national coverage indications; a service inside an indication is paid on the clinician's attestation. Congress sets the ethical frame and the numbers encoding it, and AHQB applies them — an unelected board choosing a value threshold would be illegitimate, while the same board applying one set by statute is not. The cost-effectiveness corridor governs end-stage life-prolonging therapy only; the rest of the floor is a clinical determination on evidence of benefit, with price disciplined by procurement and negotiation.
The floor expressly includes contraception, emergency contraception, sterilization, prenatal care, childbirth, postpartum care, miscarriage care, ectopic-pregnancy treatment, abortion, and treatment of reproductive-system disease.
Fertility care covers evidence-based evaluation, treatment of underlying disorders, appropriate medications, medically indicated preservation, and no more than two ovarian-stimulation and egg-retrieval cycles — with all medically appropriate transfers arising from those retrievals remaining covered.
A floor that varies by state on the most common category of care in the system is not a floor. This is a precondition of coherence rather than a coalition payment: the federal-financing argument applies here or it applies nowhere.
Fertility coverage stands on a different ground, and it is the Accord's own. The framework is organized around posterity — a fifty-year debt schedule, a two-hundred-year climate reserve, baby bonds, a future that is explicitly someone else's. A program organized around posterity cannot then means-test posterity. The premise would be self-refuting.
The intergenerational ask is mostly carbon. A price is paid now in the cost of everything, and the Climate Adaptation Trust is drawn down across two centuries for people not yet born. The household stipend returns the fee up to a ceiling; above it the money capitalizes the Trust and is not returned. So the people carrying that cost are the general population, which is also who cannot afford fertility treatment.
The claim is still about the framework rather than about anyone's account. It is not that a person who paid in is owed a child — that is the personal-benefit arithmetic the Accord refuses everywhere else, and an argument that would have to be withdrawn if the incidence shifted is not a principle. This one holds whoever pays.
That ground is narrow by design. It reaches fertility treatment, fertility preservation before cancer therapy, and maternal mortality and severe morbidity. It does not reach much else, which is what makes it a principle rather than a door.
What is committed is access to treatment. Two retrieval cycles produce a live birth somewhat more than half the time, and no treatment promises an outcome. The Accord removes the obstacle; it does not promise the result.
On cost, the retrieval cap is not the control instrument — single-embryo transfer is. Uncovered patients transfer multiple embryos to maximize per-cycle odds; multiple pregnancy drives neonatal intensive care admission, which is the actual cost. Covering IVF with a single-transfer standard is cheaper than not covering it.
The implementing statute preempts state licensure and facility regulation used to make provision impossible without banning it, and obligates Authorities to provide directly where private provision has been driven out. Absent both, coverage is universal while access varies by state.
An individual clinician may decline personally on conscience grounds. The institution remains responsible for timely disclosure, referral, transfer and actual access. No institution receiving floor payment may use conscience rules to eliminate a covered service across a catchment.
Two retrievals capture most of the yield at the steepest part of the curve: cumulative live-birth probability runs roughly 30–35% per retrieval under 35, and 55–65% cumulative after two. A third or later retrieval is supplemental or direct-pay. Medical fertility preservation is separate from the two-retrieval benefit.
Eligibility does not vary by income, marital status, sexual orientation, gender identity or method of family formation.
Gender-affirming care is evaluated under the same evidence, safety and benefit standards as every other field — no categorical exclusion and no exemption from scrutiny, with pediatric indications under specialized multidisciplinary review and long-term outcomes monitoring.
Federal preemption of state reproductive regulation invites years of constitutional litigation.
It does, and the litigation is the price of the entitlement being national. Coverage without delivery is not compliance, so the Authority obligation to provide directly is what makes the guarantee real where private provision has been driven out.
Honesty about gaps. Distributed Healthcare has more unresolved specification than other Engines because operational complexity is higher; the items below are flagged for v10.2 specification or for outside expert review.
- Reproductive-endocrinology capacity may bind before utilization does — roughly 1,500 specialists nationally against 420,000 patients.
- The model does not yet credit neonatal savings from avoided multiple births, which would strengthen the single-transfer case.